T. Rowe Price Associates’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $490M | Buy |
|
|||||
|
2025
Q2 | $173M | Sell |
|
|||||
|
2025
Q1 | $185M | Buy |
|
|||||
|
2024
Q4 | $149M | Buy |
|
|||||
|
2024
Q3 | $127M | Buy |
|
|||||
|
2024
Q2 | $98.1M | Buy |
|
|||||
|
2024
Q1 | $44.6M | Buy |
|
|||||
|
2023
Q4 | $5.05M | Buy |
|
|||||
|
2023
Q3 | $4.76M | Buy |
|
|||||
|
2023
Q2 | $3.27M | Buy |
|
|||||
|
2023
Q1 | $2.6M | Sell |
|
|||||
|
2022
Q4 | $3.02M | Sell |
|
|||||
|
2022
Q3 | $2.3M | Sell |
|
|||||
|
2022
Q2 | $2.33M | Buy |
|
|||||
|
2022
Q1 | $2.86M | Buy |
|
|||||
|
2021
Q4 | $2.48M | Buy |
|
|||||
|
2021
Q3 | $2.81M | Buy |
|
|||||
|
2021
Q2 | $2.91M | Sell |
|
|||||
|
2021
Q1 | $3.28M | Sell |
|
|||||
|
2020
Q4 | $30.4M | Sell |
|
|||||
|
2020
Q3 | $31.8M | Sell |
|
|||||
|
2020
Q2 | $34.9M | Sell |
|
|||||
|
2020
Q1 | $41.1M | Sell |
|
|||||
|
2019
Q4 | $44.6M | Buy |
|
|||||
|
2019
Q3 | $40.7M | Sell |
|
|||||
|
2019
Q2 | $41.1M | Sell |
|
|||||
|
2019
Q1 | $38M | Buy |
|
|||||
|
2018
Q4 | $40M | Sell |
|
|||||
|
2018
Q3 | $59.9M | Buy |
|
|||||
|
2018
Q2 | $33.3M | Buy |
|
|||||
|
2018
Q1 | $23.8M | Buy |
|
|||||
|
2017
Q4 | $20.2M | Sell |
|
|||||
|
2017
Q3 | $19.3M | Buy |
|
|||||
|
2017
Q2 | $19.1M | Sell |
|
|||||
|
2017
Q1 | $17.3M | Sell |
|
|||||
|
2016
Q4 | $39.7M | Sell |
|
|||||
|
2016
Q3 | $61.3M | Sell |
|
|||||
|
2016
Q2 | $76.7M | Sell |
|
|||||
|
2016
Q1 | $83.3M | Sell |
|
|||||
|
2015
Q4 | $89.9M | Sell |
|
|||||
|
2015
Q3 | $110M | Buy |
|
|||||
|
2015
Q2 | $130M | Buy |
|
|||||
|
2015
Q1 | $124M | Buy |
|
|||||
|
2014
Q4 | $106M | Buy |
|
|||||
|
2014
Q3 | $101M | Sell |
|
|||||
|
2014
Q2 | $111M | Buy |
|
|||||
|
2014
Q1 | $111M | Sell |
|
|||||
|
2013
Q4 | $110M | Sell |
|
|||||
|
2013
Q3 | $173M | Sell |
|
|||||
|
2013
Q2 | $152M | Buy |
|